Headlines Specialties Covid-19 Trending Feeds ASCO20 Videos

Gilead questions WHO study that cast doubts on drug’s COVID-19 benefits

Mashup Score: 2

Reuters Health - Gilead Sciences Inc has questioned the findings of a World Health Organization (WHO) study that concluded its COVID-19 drug remdesivir does not help patients who have been admitted to hospital.

Read the full article here

Related Content